• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于结构的促肾上腺皮质激素释放激素受体 1 拮抗剂的药物研发:使用 X 射线自由电子激光。

Structure-based drug discovery of a corticotropin-releasing hormone receptor 1 antagonist using an X-ray free-electron laser.

机构信息

Department of Systems Biology, College of Life Science and Biotechnology, Yonsei University, 50 Yonsei-ro, Seoul, 03722, Republic of Korea.

Department of Chemistry, College of Natural Sciences, Seoul National University, Seoul, 08826, Republic of Korea.

出版信息

Exp Mol Med. 2023 Sep;55(9):2039-2050. doi: 10.1038/s12276-023-01082-1. Epub 2023 Sep 1.

DOI:10.1038/s12276-023-01082-1
PMID:37653040
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10545732/
Abstract

Thus far, attempts to develop drugs that target corticotropin-releasing hormone receptor 1 (CRFR), a drug target in stress-related therapy, have been unsuccessful. Studies have focused on using high-resolution G protein-coupled receptor (GPCR) structures to develop drugs. X-ray free-electron lasers (XFELs), which prevent radiation damage and provide access to high-resolution compositions, have helped accelerate GPCR structural studies. We elucidated the crystal structure of CRFR complexed with a BMK-I-152 antagonist at 2.75 Å using fixed-target serial femtosecond crystallography. The results revealed that two unique hydrogen bonds are present in the hydrogen bond network, the stalk region forms an alpha helix and the hydrophobic network contains an antagonist binding site. We then developed two antagonists-BMK-C203 and BMK-C205-and determined the CRFR/BMK-C203 and CRFR/BMK-C205 complex structures at 2.6 and 2.2 Å, respectively. BMK-C205 exerted significant antidepressant effects in mice and, thus, may be utilized to effectively identify structure-based drugs against CRFR.

摘要

迄今为止,开发靶向促肾上腺皮质激素释放激素受体 1 (CRFR)的药物的尝试都没有成功,CRFR 是应激相关治疗的一个药物靶点。研究集中于使用高分辨率的 G 蛋白偶联受体 (GPCR) 结构来开发药物。X 射线自由电子激光 (XFEL) 可防止辐射损伤并提供高分辨率结构的获取途径,有助于加速 GPCR 结构研究。我们使用固定靶连续飞秒晶体学解析了与 BMK-I-152 拮抗剂结合的 CRFR 复合物的晶体结构,分辨率为 2.75 Å。结果表明,氢键网络中存在两个独特的氢键,柄区形成一个α螺旋,疏水区包含一个拮抗剂结合位点。我们随后开发了两种拮抗剂 BMK-C203 和 BMK-C205,并分别解析了 CRFR/BMK-C203 和 CRFR/BMK-C205 复合物的结构,分辨率分别为 2.6 和 2.2 Å。BMK-C205 在小鼠中表现出显著的抗抑郁作用,因此,可能被用于有效鉴定针对 CRFR 的基于结构的药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b6/10545732/0ae8f0bf468f/12276_2023_1082_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b6/10545732/2457f303d3a0/12276_2023_1082_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b6/10545732/765365c3c5d5/12276_2023_1082_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b6/10545732/e9ac76cf5990/12276_2023_1082_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b6/10545732/6f167215851b/12276_2023_1082_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b6/10545732/ffae0bc127a3/12276_2023_1082_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b6/10545732/0ae8f0bf468f/12276_2023_1082_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b6/10545732/2457f303d3a0/12276_2023_1082_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b6/10545732/765365c3c5d5/12276_2023_1082_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b6/10545732/e9ac76cf5990/12276_2023_1082_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b6/10545732/6f167215851b/12276_2023_1082_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b6/10545732/ffae0bc127a3/12276_2023_1082_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b6/10545732/0ae8f0bf468f/12276_2023_1082_Fig6_HTML.jpg

相似文献

1
Structure-based drug discovery of a corticotropin-releasing hormone receptor 1 antagonist using an X-ray free-electron laser.基于结构的促肾上腺皮质激素释放激素受体 1 拮抗剂的药物研发:使用 X 射线自由电子激光。
Exp Mol Med. 2023 Sep;55(9):2039-2050. doi: 10.1038/s12276-023-01082-1. Epub 2023 Sep 1.
2
An insight into antagonist binding and induced conformational dynamics of class B GPCR corticotropin-releasing factor receptor 1.深入了解B类G蛋白偶联受体促肾上腺皮质激素释放因子受体1的拮抗剂结合及诱导的构象动力学
Mol Biosyst. 2015 Jul;11(7):2042-50. doi: 10.1039/c5mb00159e.
3
Decoding Corticotropin-Releasing Factor Receptor Type 1 Crystal Structures.解析1型促肾上腺皮质激素释放因子受体晶体结构
Curr Mol Pharmacol. 2017;10(4):334-344. doi: 10.2174/1874467210666170110114727.
4
Exploration of the antagonist CP-376395 escape pathway for the corticotropin-releasing factor receptor 1 by random acceleration molecular dynamics simulations.通过随机加速分子动力学模拟探索促肾上腺皮质激素释放因子受体1的拮抗剂CP-376395逃逸途径
Mol Biosyst. 2014 Jul;10(7):1958-67. doi: 10.1039/c4mb00037d.
5
Discovery of a stable tripeptide targeting the N-domain of CRF1 receptor.发现一种稳定的三肽靶向 CRF1 受体的 N 结构域。
Amino Acids. 2020 Sep;52(9):1337-1351. doi: 10.1007/s00726-020-02895-4. Epub 2020 Sep 29.
6
Residues remote from the binding pocket control the antagonist selectivity towards the corticotropin-releasing factor receptor-1.远离结合口袋的残基控制着对促肾上腺皮质激素释放因子受体-1的拮抗剂选择性。
Sci Rep. 2015 Jan 28;5:8066. doi: 10.1038/srep08066.
7
Potential of X-ray free-electron lasers for challenging targets in structure-based drug discovery.基于结构的药物发现中具有挑战性的靶标中 X 射线自由电子激光的潜力。
Drug Discov Today Technol. 2021 Dec;39:101-110. doi: 10.1016/j.ddtec.2021.08.002. Epub 2021 Aug 26.
8
An outlook on using serial femtosecond crystallography in drug discovery.展望药物研发中连续的飞秒晶体学的应用。
Expert Opin Drug Discov. 2019 Sep;14(9):933-945. doi: 10.1080/17460441.2019.1626822. Epub 2019 Jun 11.
9
Molecular Basis for Hormone Recognition and Activation of Corticotropin-Releasing Factor Receptors.促肾上腺皮质激素释放因子受体的激素识别和激活的分子基础。
Mol Cell. 2020 Feb 6;77(3):669-680.e4. doi: 10.1016/j.molcel.2020.01.013. Epub 2020 Jan 30.
10
Femtosecond crystallography of membrane proteins in the lipidic cubic phase.脂质立方相中膜蛋白的飞秒晶体学
Philos Trans R Soc Lond B Biol Sci. 2014 Jul 17;369(1647):20130314. doi: 10.1098/rstb.2013.0314.

引用本文的文献

1
Distinctive biochemical properties of the μ-opioid receptor-corticotropin- releasing factor CRF receptor heterotetramer.μ-阿片受体-促肾上腺皮质激素释放因子(CRF)受体异源四聚体的独特生化特性。
Pharmacol Res. 2025 Aug 8;219:107904. doi: 10.1016/j.phrs.2025.107904.
2
Functional dynamics of G protein-coupled receptors reveal new routes for drug discovery.G蛋白偶联受体的功能动力学揭示了药物发现的新途径。
Nat Rev Drug Discov. 2025 Apr;24(4):251-275. doi: 10.1038/s41573-024-01083-3. Epub 2025 Jan 2.

本文引用的文献

1
Impact of GPCR Structures on Drug Discovery.G 蛋白偶联受体结构对药物发现的影响。
Cell. 2020 Apr 2;181(1):81-91. doi: 10.1016/j.cell.2020.03.003.
2
Full-length human GLP-1 receptor structure without orthosteric ligands.全长人胰高血糖素样肽-1 受体结构,无正位配体。
Nat Commun. 2020 Mar 9;11(1):1272. doi: 10.1038/s41467-020-14934-5.
3
Molecular Basis for Hormone Recognition and Activation of Corticotropin-Releasing Factor Receptors.促肾上腺皮质激素释放因子受体的激素识别和激活的分子基础。
Mol Cell. 2020 Feb 6;77(3):669-680.e4. doi: 10.1016/j.molcel.2020.01.013. Epub 2020 Jan 30.
4
Toward a Structural Understanding of Class B GPCR Peptide Binding and Activation.朝向 B 类 G 蛋白偶联受体肽结合和激活的结构理解。
Mol Cell. 2020 Feb 6;77(3):656-668.e5. doi: 10.1016/j.molcel.2020.01.012. Epub 2020 Jan 30.
5
Nylon mesh-based sample holder for fixed-target serial femtosecond crystallography.基于尼龙网的固定靶连续飞秒晶体学样品支架。
Sci Rep. 2019 May 6;9(1):6971. doi: 10.1038/s41598-019-43485-z.
6
An online resource for GPCR structure determination and analysis.一个用于 GPCR 结构测定和分析的在线资源。
Nat Methods. 2019 Feb;16(2):151-162. doi: 10.1038/s41592-018-0302-x. Epub 2019 Jan 21.
7
High-resolution crystal structure of parathyroid hormone 1 receptor in complex with a peptide agonist.甲状旁腺激素 1 受体与肽激动剂复合物的高分辨率晶体结构。
Nat Struct Mol Biol. 2018 Dec;25(12):1086-1092. doi: 10.1038/s41594-018-0151-4. Epub 2018 Nov 19.
8
Linking Aromatic Hydroxy Metabolic Functionalization of Drug Molecules to Structure and Pharmacologic Activity.将药物分子的芳香族羟基代谢功能化与其结构和药理活性联系起来。
Molecules. 2018 Aug 23;23(9):2119. doi: 10.3390/molecules23092119.
9
Discovery of 1,2,3,4-tetrahydropyrimido[1,2-a]benzimidazoles as novel class of corticotropin releasing factor 1 receptor antagonists.发现 1,2,3,4-四氢嘧啶并[1,2-a]苯并咪唑类化合物作为新型促肾上腺皮质激素释放因子 1 受体拮抗剂。
Bioorg Med Chem. 2018 May 15;26(9):2229-2250. doi: 10.1016/j.bmc.2018.01.020. Epub 2018 Feb 8.
10
Extending the Structural View of Class B GPCRs.扩展 B 类 G 蛋白偶联受体的结构观点。
Trends Biochem Sci. 2017 Dec;42(12):946-960. doi: 10.1016/j.tibs.2017.10.003. Epub 2017 Nov 11.